CSPC Pharmaceutical Group Limited
CSPCY | OTC
$4.07
+$0.13 (+3.30%)
At close: Nov 2, 2026, 3:26 PM ET
$3.94
-$0.13 (-3.19%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 6.09B | 1.31B | 2.55B | 1.31B | 3.02B | 7.39B | 2.96B | 1.51B | 3.58B | 2.55B | 3.06B |
Depreciation & Amortization | n/a | 707.6M | 691.87M | 707.48M | 631.23M | 630.85M | 530.74M | 562.78M | 580.55M | 435.47M | 428.97M |
Stock-Based Compensation | 115.23M | n/a | -72.05M | 92.16M | 118.18M | 138.13M | 118.3M | 60.45M | 84.17M | 2.13M | 5.23M |
Other Working Capital | n/a | n/a | n/a | -893.85M | n/a | -1.11B | n/a | 786.64M | n/a | -59.94M | n/a |
Other Non-Cash Items | 4.82B | 743.17M | 74.45M | 1.37B | -2.18B | -1.62B | -1.98B | 151.58M | 370.84M | 640.98M | -629.14M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | -193.4M | n/a | -3.66B | n/a | 786.64M | n/a | -1.62B | n/a |
Operating Cash Flow | 11.02B | 2.76B | 3.24B | 3.28B | 1.59B | 2.88B | 1.51B | 3.07B | 4.62B | 2B | 2.86B |
Capital Expenditures | -805.23M | -766.69M | -1.18B | -1.52B | -648.89M | -785.56M | -1.07B | -1.34B | -838.71M | -1.09B | -661.03M |
Cash Acquisitions | n/a | -22.71M | -67.08M | -153.38M | 14.08M | -15.86M | 458.46M | -32.13M | -246.01M | 61.82M | 175.26M |
Purchase of Investments | n/a | -3.66B | -1.71B | -2.27B | -2.38B | -400.74M | -4.16B | -1.52B | -5.7B | -1.57B | -3.84B |
Sales Maturities Of Investments | n/a | 2.56B | 660.74M | 2.26B | 754.22M | 647.85M | 6.14B | 2.49B | 856.83M | 3.51B | 2.5B |
Other Investing Acitivies | -6.7B | 46.42M | -1.06B | 104.87M | -65.06M | 352.65M | -222.19M | 10.8M | 1K | 36.61M | -24.31M |
Investing Cash Flow | -6.7B | -1.94B | -2.26B | -2.05B | -2.34B | -303.02M | 1.14B | -672.78M | -6.09B | 949.87M | -1.85B |
Debt Repayment | 456.28M | -183.19M | -52.31M | 28.33M | -85.92M | -22.01M | 36.17M | -380.52M | 360.25M | -840.12K | -161.79M |
Common Stock Repurchased | -280.01M | -143.6M | -272.31M | -1.43B | -379.49M | -243.81M | -199.92M | 1.07M | -16.64M | -260.25M | n/a |
Dividend Paid | n/a | -2.46B | n/a | -1.74B | -1.53B | -1.58B | -1.26B | -986.14M | -1.05B | -791.68M | -895.53M |
Other Financial Acitivies | -70.88M | 447.19M | 169.09M | 234.47M | -273.24M | 560.98M | -56.79M | 296.85M | -85.77M | -59.69M | -16.36M |
Financial Cash Flow | 105.39M | -2.32B | -152.85M | -2.82B | -2.27B | -1.35B | -1.48B | -1.07B | -792.45M | -1.12B | -1.07B |
Net Cash Flow | 4.99B | -2.17B | 1.77B | -2.49B | -2.4B | 260.06M | -251.17M | 822.82M | -624.22M | 1.34B | 886.86M |
Free Cash Flow | 10.22B | 2B | 2.06B | 1.76B | 775.86M | 2.1B | 437.76M | 1.73B | 3.78B | 913.26M | 2.2B |
Adj. Free Cash Flow | 10.1B | 2B | 2.14B | 1.67B | 657.68M | 1.96B | 319.46M | 1.66B | 3.69B | 911.13M | 2.19B |
Maintenance CapEx | n/a | -766.69M | -1.18B | -1.52B | -648.89M | -785.56M | -789.43M | -845.55M | n/a | -258.76M | -175.65M |
Growth CapEx | -805.23M | n/a | n/a | n/a | n/a | n/a | -280.68M | -497.45M | -838.71M | -829.72M | -485.38M |
Owner Earnings | 11.02B | 2B | 2.06B | 1.76B | 775.86M | 2.1B | 718.43M | 2.22B | 4.62B | 1.74B | 2.68B |
Add to Watchlist
Select watchlists to add or remove CSPCY